AAAAAA

   
Results: 1-20 |
Results: 20
FIRST-LINE FLUDARABINE TREATMENT OF SYMPTOMATIC CHRONIC LYMPHOPROLIFERATIVE DISEASES - CLINICAL-RESULTS AND MOLECULAR ANALYSIS OF MINIMAL RESIDUAL DISEASE
Authors: CLAVIO M MIGLINO M SPRIANO M PIETRASANTA D VALLEBELLA E CELESTI L CANEPA L PIERRI I CAVALIERE M BALLERINI F BELTRAMI G ROSSI E VIMERCATI R BRUNI R CONGIU M NATI S DAMASIO E SANTINI G GOBBI M
Citation: M. Clavio et al., FIRST-LINE FLUDARABINE TREATMENT OF SYMPTOMATIC CHRONIC LYMPHOPROLIFERATIVE DISEASES - CLINICAL-RESULTS AND MOLECULAR ANALYSIS OF MINIMAL RESIDUAL DISEASE, European journal of haematology, 61(3), 1998, pp. 197-203
3 STEP HIGH-DOSE CHEMOTHERAPY IN POOR-PROGNOSIS NON-HODGKIN-LYMPHOMA
Authors: BALLESTRERO A CLAVIO M FERRANDO F SECONDO V BASTA P GONELLA R GARUTI A MIGLINO M PIERRI I CANEPA L BELTRAMI G VALLEBELLA E GHIO R GOBBI M PATRONE F
Citation: A. Ballestrero et al., 3 STEP HIGH-DOSE CHEMOTHERAPY IN POOR-PROGNOSIS NON-HODGKIN-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 613-613
VDJ REARRANGEMENT MONITORING IN POOR-RISK NHL AFTER ABMT
Authors: MIGLINO M VALLEBELLA E PIETRASANTA D PALMISANO G CELESTI L CLAVIO M PIERRI I CANEPA L CONGIU M NATI S PIERLUIGI D SANTINI G GOBBI M
Citation: M. Miglino et al., VDJ REARRANGEMENT MONITORING IN POOR-RISK NHL AFTER ABMT, Bone marrow transplantation, 21, 1998, pp. 642-642
HIGH-DOSE THERAPY WITH PBPC IN MM - A PRELIMINARY-REPORT OF GENOA EXPERIENCE
Authors: FERRANDO F CLAVIO M BALLESTRERO A BALLERINI F CAVALIERE M BASTA P GONELLA R GARUTI A MIGLINO M PIERRI I BELTRAMI G GHIO R GOBBI M PATRONE F
Citation: F. Ferrando et al., HIGH-DOSE THERAPY WITH PBPC IN MM - A PRELIMINARY-REPORT OF GENOA EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 739-739
FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CERRI R PIERRI I BALLEARI E GATTO S BELTRAMI G MASOUDI B CAVALIERE M RISSO M PIETRASANTA D QUINTINO S DAMASIO E GHIO R GOBBI M
Citation: M. Clavio et al., FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 220-221
FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML
Authors: PIERRI I CLAVIO M GATTO S CERRI R CANEPA L GATTI AM BALLERINI F QUINTINO S MASOUDI B CAVALIERE M SPRIANO R GHIO R DAMASIO E GOBBI H
Citation: I. Pierri et al., FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML, British Journal of Haematology, 102(1), 1998, pp. 221-221
COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS
Authors: GOBBI M CLAVIO M MASOUDI B QUINTINO S PIERRI I CERRI R CANEPA L MUNER P RAINERO S RISSO M CAVALIERE M BELTRAMI G DAMASIO E
Citation: M. Gobbi et al., COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS, British Journal of Haematology, 102(1), 1998, pp. 227-227
MOLECULAR STUDY OF COMPLETE REMISSION IN CHRONIC LYMPHOPROLIFERATIVE DISORDERS AFTER FIRST LINE FLUDARABINE THERAPY
Authors: MIGLINO M CANEPA L PALMISANO G CLAVIO M CELESTI L SPRIANO M PIERRI I VALLEBELLA E CARRARA P CAVALIERE M PIETRASANTA D BALLERINI F BELTRAMI G SANTINI G DAMASIO E GOBBI M
Citation: M. Miglino et al., MOLECULAR STUDY OF COMPLETE REMISSION IN CHRONIC LYMPHOPROLIFERATIVE DISORDERS AFTER FIRST LINE FLUDARABINE THERAPY, Experimental hematology, 25(8), 1997, pp. 623-623
THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M QUINTINO S CERRI R RISSO M PIETRASANTA D PIERRI I BALLERINI F CAVALIERE M BELTRAMI G VALLEBELLA E CELESTI L CANEPA L SPRIANO M DAMASIO E
Citation: M. Gobbi et al., THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS, Blood, 90(10), 1997, pp. 3825-3825
ANAPLASTIC LARGE-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 53 PATIENTS
Authors: CLAVIO M ROSSI E TRUINI M CARRARA P RAVETTI JL SPRIANO M VIMERCATI AR SANTINI G CANEPA L PIERRI I CELESTI L MIGLINO M CASTELLANETA A DAMASIO E GOBBI M
Citation: M. Clavio et al., ANAPLASTIC LARGE-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 53 PATIENTS, Leukemia & lymphoma, 22(3-4), 1996, pp. 319-327
HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CARRARA P MIGLINO M PIERRI I CANEPA L BALLEARI E GATTI AM CERRI R CELESTI L VALLEBELLA E SESSAREGO M PATRONE F GHIO R DAMASIO E GOBBI M
Citation: M. Clavio et al., HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 513-520
FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M CARRARA P BALLEARI E CERRI R PIERRI I CANEPA L CELESTI L VALLEBELLA E CAVALIERE M PIETRASANTA D GENNARO M GHIO R DAMASIO E
Citation: M. Gobbi et al., FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS, Experimental hematology, 24(9), 1996, pp. 585-585
SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA
Authors: GOBBI M CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L CARRARA P GATTI AM VALLEBELLA E PIETRASANTA D CAVALIERE M DAMASIO E GHIO R
Citation: M. Gobbi et al., SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 863-863
DETECTION OF PLATELET-ASSOCIATED ANTIBODIES BY FLOW-CYTOMETRY IN HEMATOLOGICAL AUTOIMMUNE DISORDERS
Authors: TAZZARI PL RICCI F VIANELLI N TASSI C BELLETTI D PIERRI I GUGLIOTTA L GOBBI M CONTE R
Citation: Pl. Tazzari et al., DETECTION OF PLATELET-ASSOCIATED ANTIBODIES BY FLOW-CYTOMETRY IN HEMATOLOGICAL AUTOIMMUNE DISORDERS, Annals of hematology, 70(5), 1995, pp. 267-272
CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS
Authors: CARRARA P CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L RISSO M GOBBI M
Citation: P. Carrara et al., CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS, FCI. Fundamental and clinical immunology, 2(2), 1994, pp. 107-111
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY
Authors: SPRIANO M CLAVIO M CARRARA P CANEPA L MIGLINO M PIERRI I CELESTI L ROSSI E VIMERCATI R BRUNI R SANTINI G GATTI AM STURA P GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Spriano et al., FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY, Haematologica, 79(3), 1994, pp. 218-224
AN UNUSUAL REACTION TO ALPHA-INTERFERON IN A CASE OF NON-HODGKINS-LYMPHOMA
Authors: MIGLINO M PIERRI I CANEPA L CARRARA P CELESTI L GOBBI M
Citation: M. Miglino et al., AN UNUSUAL REACTION TO ALPHA-INTERFERON IN A CASE OF NON-HODGKINS-LYMPHOMA, Haematologica, 78(6), 1993, pp. 411-413
IMMUNOTHERAPY WITH INTRALESIONAL AND SYSTEMIC INTERLEUKIN-2 OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
Authors: SCUDELETTI M FILACI G IMRO MA MOTTA G DIGAETANO M PIERRI I TONGIANI S INDIVERI F PUPPO F
Citation: M. Scudeletti et al., IMMUNOTHERAPY WITH INTRALESIONAL AND SYSTEMIC INTERLEUKIN-2 OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER, Cancer immunology and immunotherapy, 37(2), 1993, pp. 119-124
Risultati: 1-20 |